MFGM Phospholipid Trial Shows Limited Cognitive Effect in Older Adults

What Was Studied

Researchers tested milk fat globule membrane phospholipid supplementation in older adults with subjective memory complaints using a randomized, double-blind, placebo-controlled design.

The work examined cognition in a group where phospholipid support is commercially relevant but where evidence in otherwise healthy older adults has remained limited.

What the Trial Reported

According to the PubMed summary, the study did not find significant overall effects on cognitive function.

The same summary says subjective alertness during testing improved in the high-dose group, alongside reductions in inflammation-related and lipid markers discussed by the authors.

Buyer Takeaway

For buyers in healthy-aging categories, the result is a reminder that phospholipid-rich ingredients may generate nuanced outcomes rather than a simple headline efficacy claim.

Study population, endpoint choice, and dose level all matter when deciding how much evidence is strong enough for a formulation story or technical sales file.

Sources

• The effect of milk fat globule membrane phospholipid supplementation on cognitive function in older adults with subjective memory complaints-a randomized, double-blind, placebo-controlled trial
• The effect of milk fat globule membrane phospholipid supplementation on cognitive function in older adults with subjective memory complaints-a randomized, double-blind, placebo-controlled trial - PMC